Involvement of mitochondria in Parkinson's disease

CJ Choong, H Mochizuki - International Journal of Molecular Sciences, 2023 - mdpi.com
Mitochondrial dysregulation, such as mitochondrial complex I deficiency, increased
oxidative stress, perturbation of mitochondrial dynamics and mitophagy, has long been …

Enhancing CNS mitophagy: drug development and disease-relevant models

KS Dhar, B Townsend, AP Montgomery… - Trends in …, 2024 - cell.com
Mitophagy, the selective degradation of mitochondria, is impaired in many
neurodegenerative diseases (NDs), resulting in an accumulation of dysfunctional …

Mitochondrial CISD1/Cisd accumulation blocks mitophagy and genetic or pharmacological inhibition rescues neurodegenerative phenotypes in Pink1/parkin models

A Martinez, A Sanchez-Martinez, JT Pickering… - Molecular …, 2024 - Springer
Background Mitochondrial dysfunction and toxic protein aggregates have been shown to be
key features in the pathogenesis of neurodegenerative diseases, such as Parkinson's …

Lysosomal genes contribute to Parkinson's disease near agriculture with high intensity pesticide use

KJ Ngo, KC Paul, D Wong, CDJ Kusters… - npj Parkinson's …, 2024 - nature.com
Abstract Parkinson's disease (PD), the second most common neurodegenerative disorder,
develops sporadically, likely through a combination of polygenic and environmental factors …

miRNA‐137‐5p improves spatial memory and cognition in Alzheimer's mice by targeting ubiquitin‐specific peptidase 30

Y Jiang, W Bian, J Chen, X Cao… - Animal Models and …, 2023 - Wiley Online Library
Background Alzheimer's disease (AD) is a prevalent neurodegenerative disorder causing
progressive dementia. Research suggests that microRNAs (miRNAs) could serve as …

Activation of the Keap1/Nrf2 pathway suppresses mitochondrial dysfunction, oxidative stress, and motor phenotypes in C9orf72 ALS/FTD models

WH Au, L Miller-Fleming… - Life Science …, 2024 - life-science-alliance.org
Mitochondrial dysfunction is a common feature of C9orf72 amyotrophic lateral sclerosis/
frontotemporal dementia (ALS/FTD); however, it remains unclear whether this is a cause or …

Activation of the Keap1/Nrf2 pathway suppresses mitochondrial dysfunction in C9orf72 ALS/FTD in vivo models and patient iNeurons

WH Au, L Miller-Fleming, A Sanchez-Martinez, JAK Lee… - bioRxiv, 2023 - biorxiv.org
Mitochondrial dysfunction such as excess production of reactive oxygen species (ROS) and
defective mitochondrial dynamics are common features of C9orf72 Amyotrophic Lateral …

Therapeutic potential of Parkin and its regulation in Parkinson's disease

N Safreena, IC Nair, G Chandra - Biochemical Pharmacology, 2024 - Elsevier
Parkinson's disease (PD) is a debilitating neurodegenerative disorder characterized by the
progressive loss of dopaminergic neurons in the midbrain substantia nigra, resulting in …

Study of an FBXO7 patient mutation reveals Fbxo7 and PI31 co‐regulate proteasomes and mitochondria

S Al Rawi, L Simpson, G Agnarsdóttir… - The FEBS …, 2024 - Wiley Online Library
Mutations in FBXO7 have been discovered to be associated with an atypical parkinsonism.
We report here a new homozygous missense mutation in a paediatric patient that causes an …

The autophagy–lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson's disease

F Jiao, L Meng, K Du, X Li - Neural Regeneration Research, 2025 - journals.lww.com
Parkinson's disease is a common neurodegenerative disease with movement disorders
associated with the intracytoplasmic deposition of aggregate proteins such as α-synuclein in …